nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—Neutropenic colitis—Topotecan—cervical cancer	0.195	0.195	CcSEcCtD
Aprepitant—Mucosal inflammation—Topotecan—cervical cancer	0.0406	0.0406	CcSEcCtD
Aprepitant—Febrile neutropenia—Topotecan—cervical cancer	0.0374	0.0374	CcSEcCtD
Aprepitant—Pelvic pain—Topotecan—cervical cancer	0.0369	0.0369	CcSEcCtD
Aprepitant—Heartburn—Topotecan—cervical cancer	0.0327	0.0327	CcSEcCtD
Aprepitant—Rigors—Topotecan—cervical cancer	0.0275	0.0275	CcSEcCtD
Aprepitant—Blood bilirubin increased—Topotecan—cervical cancer	0.0238	0.0238	CcSEcCtD
Aprepitant—Respiratory failure—Topotecan—cervical cancer	0.0229	0.0229	CcSEcCtD
Aprepitant—Pulmonary embolism—Topotecan—cervical cancer	0.0225	0.0225	CcSEcCtD
Aprepitant—Neoplasm—Topotecan—cervical cancer	0.0203	0.0203	CcSEcCtD
Aprepitant—Lethargy—Topotecan—cervical cancer	0.0166	0.0166	CcSEcCtD
Aprepitant—Cramp muscle—Topotecan—cervical cancer	0.0147	0.0147	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.0147	0.0147	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Topotecan—cervical cancer	0.0144	0.0144	CcSEcCtD
Aprepitant—Neutropenia—Topotecan—cervical cancer	0.0132	0.0132	CcSEcCtD
Aprepitant—Weight increased—Topotecan—cervical cancer	0.0128	0.0128	CcSEcCtD
Aprepitant—Pneumonia—Topotecan—cervical cancer	0.0126	0.0126	CcSEcCtD
Aprepitant—Infestation—Topotecan—cervical cancer	0.0126	0.0126	CcSEcCtD
Aprepitant—Infestation NOS—Topotecan—cervical cancer	0.0126	0.0126	CcSEcCtD
Aprepitant—Neuropathy peripheral—Topotecan—cervical cancer	0.0123	0.0123	CcSEcCtD
Aprepitant—Stomatitis—Topotecan—cervical cancer	0.0123	0.0123	CcSEcCtD
Aprepitant—Hypoaesthesia—Topotecan—cervical cancer	0.0112	0.0112	CcSEcCtD
Aprepitant—Pharyngitis—Topotecan—cervical cancer	0.0112	0.0112	CcSEcCtD
Aprepitant—Angiopathy—Topotecan—cervical cancer	0.0102	0.0102	CcSEcCtD
Aprepitant—Immune system disorder—Topotecan—cervical cancer	0.0102	0.0102	CcSEcCtD
Aprepitant—Mediastinal disorder—Topotecan—cervical cancer	0.0102	0.0102	CcSEcCtD
Aprepitant—Chills—Topotecan—cervical cancer	0.0101	0.0101	CcSEcCtD
Aprepitant—Alopecia—Topotecan—cervical cancer	0.00997	0.00997	CcSEcCtD
Aprepitant—Malnutrition—Topotecan—cervical cancer	0.00983	0.00983	CcSEcCtD
Aprepitant—Back pain—Topotecan—cervical cancer	0.0095	0.0095	CcSEcCtD
Aprepitant—Muscle spasms—Topotecan—cervical cancer	0.00945	0.00945	CcSEcCtD
Aprepitant—Ill-defined disorder—Topotecan—cervical cancer	0.00912	0.00912	CcSEcCtD
Aprepitant—Anaemia—Topotecan—cervical cancer	0.00908	0.00908	CcSEcCtD
Aprepitant—Angioedema—Topotecan—cervical cancer	0.00898	0.00898	CcSEcCtD
Aprepitant—Malaise—Topotecan—cervical cancer	0.00886	0.00886	CcSEcCtD
Aprepitant—Cough—Topotecan—cervical cancer	0.00857	0.00857	CcSEcCtD
Aprepitant—Myalgia—Topotecan—cervical cancer	0.00837	0.00837	CcSEcCtD
Aprepitant—Arthralgia—Topotecan—cervical cancer	0.00837	0.00837	CcSEcCtD
Aprepitant—Chest pain—Topotecan—cervical cancer	0.00837	0.00837	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00831	0.00831	CcSEcCtD
Aprepitant—Discomfort—Topotecan—cervical cancer	0.00826	0.00826	CcSEcCtD
Aprepitant—Anaphylactic shock—Topotecan—cervical cancer	0.00802	0.00802	CcSEcCtD
Aprepitant—Infection—Topotecan—cervical cancer	0.00797	0.00797	CcSEcCtD
Aprepitant—Nervous system disorder—Topotecan—cervical cancer	0.00786	0.00786	CcSEcCtD
Aprepitant—Thrombocytopenia—Topotecan—cervical cancer	0.00785	0.00785	CcSEcCtD
Aprepitant—Skin disorder—Topotecan—cervical cancer	0.00779	0.00779	CcSEcCtD
Aprepitant—Hyperhidrosis—Topotecan—cervical cancer	0.00775	0.00775	CcSEcCtD
Aprepitant—Anorexia—Topotecan—cervical cancer	0.00764	0.00764	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00731	0.00731	CcSEcCtD
Aprepitant—Paraesthesia—Topotecan—cervical cancer	0.0072	0.0072	CcSEcCtD
Aprepitant—Dyspnoea—Topotecan—cervical cancer	0.00715	0.00715	CcSEcCtD
Aprepitant—Dyspepsia—Topotecan—cervical cancer	0.00706	0.00706	CcSEcCtD
Aprepitant—Decreased appetite—Topotecan—cervical cancer	0.00697	0.00697	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Topotecan—cervical cancer	0.00692	0.00692	CcSEcCtD
Aprepitant—Fatigue—Topotecan—cervical cancer	0.00691	0.00691	CcSEcCtD
Aprepitant—Constipation—Topotecan—cervical cancer	0.00686	0.00686	CcSEcCtD
Aprepitant—Pain—Topotecan—cervical cancer	0.00686	0.00686	CcSEcCtD
Aprepitant—Feeling abnormal—Topotecan—cervical cancer	0.00661	0.00661	CcSEcCtD
Aprepitant—Gastrointestinal pain—Topotecan—cervical cancer	0.00656	0.00656	CcSEcCtD
Aprepitant—Urticaria—Topotecan—cervical cancer	0.00637	0.00637	CcSEcCtD
Aprepitant—Abdominal pain—Topotecan—cervical cancer	0.00634	0.00634	CcSEcCtD
Aprepitant—Body temperature increased—Topotecan—cervical cancer	0.00634	0.00634	CcSEcCtD
Aprepitant—Hypersensitivity—Topotecan—cervical cancer	0.00591	0.00591	CcSEcCtD
Aprepitant—Asthenia—Topotecan—cervical cancer	0.00575	0.00575	CcSEcCtD
Aprepitant—Pruritus—Topotecan—cervical cancer	0.00567	0.00567	CcSEcCtD
Aprepitant—Diarrhoea—Topotecan—cervical cancer	0.00549	0.00549	CcSEcCtD
Aprepitant—Dizziness—Topotecan—cervical cancer	0.0053	0.0053	CcSEcCtD
Aprepitant—Vomiting—Topotecan—cervical cancer	0.0051	0.0051	CcSEcCtD
Aprepitant—Rash—Topotecan—cervical cancer	0.00506	0.00506	CcSEcCtD
Aprepitant—Dermatitis—Topotecan—cervical cancer	0.00505	0.00505	CcSEcCtD
Aprepitant—Headache—Topotecan—cervical cancer	0.00502	0.00502	CcSEcCtD
Aprepitant—Nausea—Topotecan—cervical cancer	0.00476	0.00476	CcSEcCtD
